Rezultati - Jyun-Yan Yang

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial od Vladimir Skljarevski, Manjit Matharu, Brian A. Millen, Michael H. Ossipov, Byung‐Kun Kim, Jyun Yan Yang

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

    Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment od David W. Dodick, Peter J. Goadsby, Christian Lucas, Rigmor Jensen, Jennifer Bardos, James M. Martinez, Chunmei Zhou, Sheena K. Aurora, Jyun Yan Yang, Robert R. Conley, Tina M. Oakes

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Trial of Galcanezumab in Prevention of Episodic Cluster Headache

    Trial of Galcanezumab in Prevention of Episodic Cluster Headache od Peter J. Goadsby, David W. Dodick, Massimo Leone, Jennifer Bardos, Tina M. Oakes, Brian A. Millen, Chunmei Zhou, Sherie A. Dowsett, Sheena K. Aurora, Andrew H. Ahn, Jyun-Yan Yang, Robert R. Conley, James M. Martinez

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: